Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Variations and Cardiometabolic Risk in Antipsychotic Treatment
NCT02986490Unknown
- Sponsor
- CHU Montpellier
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Montpellier. Primary endpoint: Proportion of patients with changes from baseline cardiometabolic risk at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT02986490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986490.